The Relationship Between Interferon Status and HPV Infection in Patients With Oral Epithelial Dysplasia
Key facts
- Who runs it
- I.M. Sechenov First Moscow State Medical University
- Where
- Russia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 74 people enrolled
- Started
- 28 Nov 2020
- Ended
- 5 Nov 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Excision of the OED site with a fiber laser
- Excision of the OED site with a scalpel
- Record updated
- 1 July 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- The patient's written informed consent to participate in the study
- Men and women aged 18-80 years
- Verified diagnoses K 13.2 "Leukoplakia and other changes in the oral epithelium", L 43 "Lichen planus" with pathohistological signs of epithelial dysplasia
- Patients who, after conservative treatment of lesions of the oral mucosa, have not achieved a therapeutic effect and have indications for surgery; Non-inclusion criteria:
- Patients who have achieved the therapeutic effect of the disease after conservative treatment
- Patients who have symptoms of malignant transformation and who could not / did not want to make all necessary visits to the doctor
- Pregnant women and during lactation, women who planned pregnancy during this study
Who cannot take part
- The onset of an exacerbation of concomitant pathology
- Allergic reaction to medications used
- Patient's refusal to continue participating in the study
- Pregnancy
- A change in the state of health that, in the researcher's opinion, prevents the patient from continuing to participate in the study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is an interventional prospective randomized clinical trial (RCT) in parallel groups. The sample size is 74 patients who were randomly divided into two groups depending on the surgical intervention used. First group - patients who underwent surgery to excise the affected oral mucosa with a fiber laser with a wavelength of 1.94 micrometers (LSP-IRE- Polyus, Moscow, Russia). Second group - patients who underwent surgery using the traditional scalpel technique (No. 15C). At the examination stage, patients were referred for evaluation of interferon status according to the following indicators: biological activity of serum interferon (IFN), spontaneous IFN, IFN-alpha/beta, IFN-gamma.
Read full original descriptionShow less
In the postoperative period the dynamics of postoperative epithelialization, the severity of edema, hyperemia and pain syndrome were evaluated. Also, the postoperative material was sent for a molecular genetic study of HPV infection by PCR diagnostics and pathohistological examination followed by immunohistochemical analysis to determine the expression of oncoproteins p16 and p53.
The 2 groups in the trial
- first groupExisting treatment, for comparison
Patients undergoing surgery to excise the affected oral mucosa will be treated with a fiber laser with a wavelength of 1.94 micrometers.
Treatment: Excision of the OED site with a fiber laser
- second groupTreatment being tested
Patients who will have surgery to excise the affected oral mucosa with a scalpel (No. 15C).
Treatment: Excision of the OED site with a scalpel
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Use of Laser Technologies in the Surgical Treatment of Patients With Oral Epithelial Dysplasia
- Record updated
- 1 July 2026